Cerebral ischemia is one of the most common diseases resulting in death and disability in aged people. It leads immediately to rapid energy failure, ATP depletion, and ionic imbalance, which increase extracellular ATP levels and accordingly activate P2X 7 receptors. These receptors are ATP-gated cation channels and widely distributed in nerve cells, especially in the immunocompetent cells of the brain. Currently, interest in the roles of P2X 7 receptors in ischemic brain injury is growing. In this review, we discuss recent research progress on the actions of P2X 7 receptors, their possible mechanisms in cerebral ischemia, and the potential therapeutic value of P2X 7 receptor antagonists which may provide a new target both for clinical and for research purposes.
Introduction
Cerebral ischemia remains a major cause of morbidity and mortality worldwide in aged people and affects millions every year. Immediately after ischemia, the cerebral blood flow dramatically decreases in the ischemic core, leading to rapid energy failure, ATP depletion, ionic imbalance, and neuronal death [1] . The cells in the penumbra (tissues surrounding the ischemic core), however, can retain their activity for a prolonged period. The neurodegenerative episodes and neuronal loss gradually expand from the ischemic core to the penumbra in the following several days. Therefore, effective interventions in this period are essential.
Extracellular ATP is an important signaling molecule mediating interactions among various types of cells in the central nervous system (CNS) [2] . It acts on cell-surface P2 purinoceptors and serves as a neurotransmitter, neuromodulator, and trophic factor under physiological conditions. On the other hand, pathological events such as mechanical or metabolic stress, inflammation, cellular injury, or changes in the ionic environment are all known to powerfully stimulate ATP release. This results in an ATP-rich extracellular environment leading to widespread activation of receptors on astrocytes and microglia and boosting diverse pathological cascades, such as glutamatergic excitotoxicity, and oxidative damage, as well as IL-1β and other cytokine-mediated signaling [3] . P2
receptors are classified into two subfamilies, P2X and P2Y.
ATP couples to the ligand-gated P2X ion channel receptors and mediates fast excitatory neurotransmission, while ATP binds to the GTP-binding P2Y receptors to evoke slow excitatory responses. Seven distinct ionotropic P2X (P2X [1] [2] [3] [4] [5] [6] [7] and eight distinct metabotropic P2Y receptor subunits (P2Y 1,2,4,6,11-14 ), classified by electrophysiological properties and their amino-acid sequence homology, have been cloned from mammals [4] .
P2X receptors are widely distributed in excitable and non-excitable cells of vertebrates. They play key roles in regulating afferent signaling (including pain), renal blood flow, the vascular endothelium, inflammatory responses, tumorigenesis, CNS injury, and embryonic development [5, 6] .
Of the P2X family, the P2X 7 receptor (P2X 7 R) has specific structural and pharmacological features and may play a prominent role in the progression of various neurological disorders, such as cerebral ischemic injury (stroke), [3, 7, 8] .
In the past few years, the potential role of this receptor in neuronal functions during cerebral ischemic stroke has received considerable attention.
Nevertheless, a major debate has emerged on the roles of activated P2X 7 Rs in animal and cellular models of this disorder. Most indicate that up-regulation or overactivation of P2X 7 Rs aggravate the brain tissue damage and sensorimotor deficit through several mechanisms such as Ca 2+ overload which induces excitotoxic neuronal death or apoptosis, and receptor antagonists play a protective role [1, 4, [9] [10] [11] [12] . However, a few reports are contradictory [13, 14] .
In the following we thus review the unique properties of P2X 7 Rs compared to other P2X receptor family members, the possible mechanisms of their actions in cerebral ischemia, and the potential therapeutic exploitation of P2X 7 R antagonists.
P2X 7 Receptors and Their Unusual Properties

Compared with Other P2X Family Receptors
The P2X 7 R was first discovered by Buisman in 1988 and
Gordon named it the P2z receptor [15] meaning ''cell death receptor'' [3] or "suicide receptor" [5] because its prolonged activation leads to cellular death. In 1996, the P2X 7 R was first cloned from a rat brain cDNA library and classified as a member of the P2X receptor family [7] . P2X 7 Rs have several properties that set them apart from other members of the P2X receptor family. First, the P2X 7 R is 595 amino-acids long, having 35-40% homology with the other six members of the family [3] .
Only the P2X 7 R does not heterotrimerize with other P2X subunits. However, it was shown recently that P2X 7 R subunits functionally interact with P2X 4 subunits in macrophages. The heteromeric P2X 4 /P2X 7 receptor appears to have the pharmacological properties of both of the homomeric receptor subtypes [10] . Second, except for two transmembrane domains (M1 and M2) and a large extracellular loop containing the ATP-binding site [16] , the P2X 7 R has a unique structural feature: its intracellular carboxy terminal domain is much longer (239 amino-acids) than those of the other P2X receptor subunits amino-acids). This long C-terminal tail can combine with many downstream proteins and lipids in the cytoplasm [7] , and this is associated with unique functions as well as cellular localization [17] . Third, in contrast to other P2X receptors, the P2X 7 R has a lower affinity for ATP [18] , and only relatively higher concentrations of extracellular ATP (millimolar range) can activate P2X 7 Rs relative to other P2X receptors (micromolar range) [7, 10, 19] . Last but not least, P2X 7 Rs are bifunctional because they have two states, cation channels and plasma membrane pores [20] . When stimulated by lower concentrations of ATP, P2X 7 Rs are mildly activated and function as small cation channels with a permeability significantly higher to Ca 2+ than to Na + and K + [9] . Repetitive or prolonged exposure to higher concentrations of ATP elicits progressive dilation of the receptor cation channel, which finally forms a large irreversible and nonselective transmembrane pore permeable to macromolecules up to 900 Da in size [1, 3, 21] .
This promotes actin disaggregation, rapid cytoskeletal rearrangement, membrane blebbing, cytokine release, and finally apoptosis and cell death [9] . Wang et al. [22] reported that spinal cord injury is associated with high ATP release that lasts for at least 6 h after the initial injury. Exposure of P2X 7 Rs on spinal cord neurons to ATP leads to highfrequency spiking, an irreversible increase in cytosolic Ca
2+
and cell death, while P2X 7 R antagonists inhibit this process and facilitate functional recovery. Another study indicated that the ATP concentration in the striatum of normoxic rats is 3.10 ± 0.34 nmol/L. During 220 min after middle cerebral artery occlusion (MCAO), extracellular ATP levels significantly increase to 5.90 ± 0.61 nmol/L [23] . In addition, stimulation of P2X 7 Rs with high concentrations of ATP has dramatic cytotoxic actions in many neurodegenerative processes [24] .
Activation of P2X 7 Receptors in Ischemic Brain
Injury
P2X 7 Receptor Expression in the CNS under
Physiological Conditions
Under normal conditions, P2X 7 Rs are widespread on the membranes of neurons, astrocytes, microglia, oligodendrocytes, and oligodendrocyte precursor cells, as well as Schwann cells [14, [25] [26] [27] , unlike the localization of P2X [1] [2] [3] [4] [5] [6] receptor subtypes, which is mainly on the membranes of neurons [28] . They are especially abundant on microglia that are in a physiologically resting state, [20] , and play protective roles such as host defense and tissue repair [28] against neuronal damage [29] , suggesting that P2X 7 Rs are involved in immune functions and inflammatory responses [13] . The cellular localization of P2X 7 Rs in the CNS remains controversial. Yu et al.
described the precise distribution of P2X 7 mRNA in the rat brain using isotopic in situ hybridization. Small P2X 7 -positive glial-like cells are sporadically scattered in almost all areas of the brain [30] . In neurons, P2X 7 Rs are primarily distributed on presynaptic terminals in the medulla oblongata and spinal cord, excitatory nerve terminals of CA1, CA3, the dentate gyrus and mossy fibers of the hippocampus, cortical synaptosomes, neuronal cell bodies of the medulla oblongata and hippocampus [1] and the nuclear envelope of postsynaptic neurons [11] . P2X 7 Rs on the presynaptic membrane might serve as sensors of neuronal activity and extracellular ATP release, whereas the receptors on the nuclear envelope, regulated by cytoplasmic ATP, may be a mechanism of changing gene expression [31] .
Altered Expression and Function of P2X 7
Receptors in Cerebral Ischemia
Many studies have suggested that, after cerebral ischemia, activated P2X 7 Rs are expressed predominantly on activated microglia in the penumbra and on reactive microglia. Reactive microglia are in a state intermediate between activation and rest. They are at rest in shape but have positive P2X 7 R immunoreactivity in remote projection areas such as the cingulate and medial frontal cortex and the synaptic terminals of neurons [4, 13] . Activation of P2X 7 Rs contributes to post-anoxic depolarization and neuronal demise following ischemia [9] .
Oxygen/glucose deprivation (OGD) in the ex vivo model of organotypic hippocampal slice cultures rapidly and transiently up-regulates P2X 7 Rs in a time-dependent manner in the parallel fibers of the pyramidal cell layer in CA1 and CA2 [11] . They directly participate in the metabolic impairment. OGD in mixed astrocytic/neuronal cultures selectively up-regulates P2X 7 R immunoreactivity in the plasma membrane of neurons, but not astrocytes, 12 h after ischemia [25] . Post-ischemic, time-dependent up-regulation of the P2X 7 R subtype on neurons and microglia in the MCAO model might be involved in neuronal apoptosis and tissue damage, suggesting a role of this receptor in the pathophysiology of cerebral ischemia in vivo [1, 4] .
Besides, a transient and significant enhancement in P2X 7
protein expression was reported to occur immediately after asphyxia in a rat model of intrauterine asphyxia [32] .
However, inconsistent with most reports that P2X 7 [27] . However, Lee reported that in a rat model of anoxia-induced brain ischemia and reperfusion (I/R) injury, the whole brain P2X 7 R expression is unchanged at 6 h after anoxia [33] . The differences in the maturation status of brain tissue, and the manner and distribution of hypoxic-ischemic damage between the perinatal and adult brain might explain these discrepancies. The P2X 7 R-containing cells are lost in response to ischemia, which limits the detrimental consequences of post-ischemic brain injury. Depending on the diverse conditions of a given study, P2X 7 Rs may increase, decrease, or even fail to alter the infarct size [1] . Further, polymorphisms of the Although most studies demonstrated that blocking the P2X 7 Rs improves the neuronal injury in vivo and in vitro [22, 34] , Le Feuvre suggested that neither the knockout of P2X 7 Rs nor P2X 7 R antagonists affect the infarct volume in MCAO and in glutamate toxicity [12] . This may be explained by the activation of alternative compensatory pathways and thus suggests that the simple genetic deletion of P2X 7 Rs might not be the right model to investigate their roles [3] . So far, little has been done to study P2X 7 knockout in ischemia, and further studies are needed to elucidate the exact effects and specific mechanisms underlying the P2X 7 R knockout genotype in cerebral ischemia.
Possible Mechanisms of Action of Activated P2X 7
Receptors after Cerebral Ischemia Activated P2X 7 Receptors Induce Ca 2+ Overload
Leading to Cell Death
Cerebral ischemia induces excessive ATP release into the extracellular space from the cytoplasm of damaged and dying cells due to nucleic acid degradation and membrane permeability [1, 35] . There are several possible modes of ATP release: (1) damaged neurons are depolarized by the elevated extracellular K + due to impairment of the Na + -K + pump. ATP passively flows out along the electrochemical gradient through membrane channels of glial cells [23] or from the presynaptic vesicles exocytotically [35] ; (2) organelles release ATP from astroglia in a Ca 2+ -independent manner via P2X 7 R channels [25, 36] ; and (3) P2X 7 Rs on activated amoeboid microglia and reactive microglia amplify the ATP signal and trigger ATP release through an autocrine process [37, 38] . In short, cerebral ischemia results in a sustained progressive elevation of ATP levels in the penumbra [22, 23] .
The relatively high micromolar level of ATP in the extracellular space powerfully activates the P2X 7 Rs and leads to the formation of excitotoxic cytolytic pores [2, 39] and cell death.
Calcium overload is the prominent mechanism of P2X 7 R-mediated excitotoxic cell injury in stroke as well as in vitro models. Activated P2X 7 Rs contribute directly to a rapid increase of intracellular Ca 2+ [40] (due to the massive influx of extracellular Ca 2+ via P2X 7 R membrane pores) [1, 41] . The resulting depolarization causes the secondary activation of voltage-gated Ca 2+ channels [41] [42] [43] , and intracellular Ca 2+ continuously increases. The high concentration of intracellular Ca 2+ activates nucleases and proteases (e.g., calpains) which eventually result in cell death [44] .
Meanwhile, the mitochondrial matrix also takes Ca 2+ from the cytoplasm. When the Ca 2+ level in the mitochondrial matrix reaches a toxic threshold, the mitochondrial membrane potential collapses, the permeability transition pore opens, ions and solutes including Ca 2+ flow into the cytosol [45] and activate the apoptotic caspase enzyme system [17] . Despite the massive downstream effects of Ca 2+ overload, only a few intracellular signaling pathways have been described in detail. Currently, it has been shown that the ERK1/2 MAP kinase pathway contributes to the pathological consequences of OGD in the cultured hippocampal slice [43] .
Pannexins are large membrane channels with broad expression throughout the body and have various functions. Pannexin-1 (Px1) is robustly expressed in the brain [47] . The opening of Px1 hemichannels is regulated by activated P2X 7 Rs under pathological conditions such as ischemia, and is responsible for the massive influx of Ca 2+ from the extracellular space. Iwabuchi et al. [46] reported recently that in cultured astrocytes, the suppression of 
Activated P2X 7 Receptors Induce Neuroinflammation as a Double-edged Sword
Numerous studies indicate that P2X 7 Rs also participate in the regulation of neuroinflammation and neuroimmune reactions as an inflammatory mediator in the CNS [49] [50] [51] [52] [53] . [47] .
However, in early stages of ischemic injury, microglial activation might be protective to the brain via P2X 7 Rs.
During this time, the low concentration of ATP acts as a chemoattractant for microglial recognition and migration [48] , directing them to the site of injury [49] . Like macrophages, activated microglia may remove potentially deleterious necrotic cell debris from the ischemic core, promote tissue repair, and thus contribute to neuroprotection [7] . On the other hand, activated microglia release neurotrophic factors via activated P2X 7 Rs and enhance neuronal survival [50] .
P2X 7 R-activated microglia in neuron-microglia co-cultures protect neurons against glutamate toxicity primarily by releasing tumor necrosis factor-α (TNF-α) [50] . Lack of microglia elevates the levels of several brain cytokines and chemokines such as IL-1β, TNF-α, CINC-1 and MCP-1, and increases the severity and volume of injury, indicating that microglia contribute to the endogenous protection against early injury after neonatal stroke [48] .
Nevertheless, in the later stages of cerebral ischemia, the high level of ATP stimulates microglial P2X 7 R overexpression (pore formation) [47] and leads to microglial activation, proliferation [51] and cell death. Over-activated microglia up-regulate the expression of their surface immunomodulatory proteins and release potentially neurotoxic pro-inflammatory cytokines such as IL-1β, IL-6
and TNF-α [16, 47] . These pro-inflammatory cytokines boost further microglial activation in an autocrine manner [16, 47] and induce secondary inflammatory injury in the penumbra [22, 50] which is an exaggerated and prolonged inflammatory response that results in continued neuronal cell death (not only damaged cells but also neighboring healthy cells) [10, 16] .
Three models were recently proposed to explain the non-classical secretion of mature IL-1β following P2X 7 R activation [52] . The oldest and simplest model suggests that P2X 7 R-mediated cytolysis directly triggers rapid caspase-1 activation followed by the release of mature IL-1β [10, 53] depending on the K + and Ca 2+ efflux [54] . The other two models include the involvement of P2X 7 R-induced microvesicle shedding [24] or lysosome exocytosis from the plasma membrane into the extracellular medium [55] .
Activated P2X 7 Receptors Modulate Neurotransmitter Release
A series of functional data strongly supports the role of P2X 7 Rs in information processing in the normal and pathological nervous systems [25] . Several investigations s u g g e s t t h a t a f t e r c e r e b r a l i s c h e m i c i n j u r y, t h e extracellularly-accumulated ATP facilitates glutamate and gamma-aminobutyric acid (GABA) release from the terminals of neurons, astrocytes, and cortical microglia upon energy deprivation [3, 56] .
The up-regulation and extensive activation of P2X 7 Rs quickly inhibit glutamate uptake [57] , empty the cytoplasmic glutamate store, promote glutamate release and accumulation [42] , alter glutamate homeostasis, and trigger cell death [58] . Possibly, the activation of P2X 7 Rs simultaneously opens both cation channels permeable to large cations and anion channels permeable to organic anions such as L-glutamate and D-aspartate, mediating rapid non-vesicular glutamate release [26] . In a study of perinatal acute asphyxia, glutamate was verified to be released via the P2X 7 R channel [32] .
Although P2X 7 R channels are not selectively permeable to glutamate, the powerful driving force along the Na + and K + electrochemical gradient is responsible for significant glutamate efflux. Another underlying mechanism of glutamate release is that the insufficient energy supply and depolarization induced by ischemia cause a direct Na + influx, contributing to intracellular Na + overload which leads to the opening of voltage-sensitive Na + channels [42] .
Consequently, endogenous over-activation of P2X 7 Rs participates in post-ischemic brain injury as an amplifying factor for glutamatergic excitotoxicity [42] . Excessive extracellular glutamate even forms a feedback loop and further down-regulates P2X 7 Rs [32] . It is noteworthy that this loop may represent a cellular effort to counteract and possibly halt the detrimental outcome of progressive neuronal damage.
GABA efflux is also dependent on the Na + and K + electrochemical gradients. Cerebral ischemia appears to markedly increase P2X 7 R-mediated GABA release, which may limit the severity of ischemic brain injury.
Augmentation of the excitatory glutamatergic system facilitates the ischemia-induced neuronal damage, whereas augmentation of the inhibitory GABAergic system is neuroprotective. Therefore, the sum of these two opposing mechanisms may determine the infarct size [1] .
Therapeutic Potential of P2X 7 Receptor Antagonists in Ischemic Brain Injury
Since the up-regulation of the P2X 7 R system may stimulate and A-438079 [59] .
Among these, BBG and OxATP are the most widely used in recent studies of P2X 7 Rs. However, both suffer from relatively poor specificity [51] . OxATP has strong antagonistic effects not only on P2X 7 Rs, but also on other P2X receptors, and even P2Y receptors. It attenuates proinflammatory signaling by mechanisms independent of the expression or activation of P2 receptor subtypes [60] .
This occurs in P2X 7 R-knockout mice, suggesting that one or more other P2 receptors are required [61] . BBG has nanomolar affinity for rat P2X 7 Rs and only micromolar affinity for some other P2X receptors.
Of the various P2X 7 R antagonists, BBG is the most potent, noncompetitive antagonist. BBG is derived from a blue food-dye, has been shown to be safe in healthy animals, and is approved for foodstuff use. It has low toxicity and can cross the blood-brain barrier [7] . [9, 10, 51] . BBG drastically increases neuronal tolerance to mitochondrial dysfunction and glutamate release [10] . It locks the mitochondria and prevents neuronal death by blocking the mitochondrial Ca 2+ uptake and discharge of the mitochondrial membrane potential.
OxATP has been regarded as a selective P2X 7 R antagonist for a considerable time. It is a slowly-equilibrating and irreversible antagonist of P2X 7 Rs. OxATP has been widely used as a probe to identify P2X 7 R-mediated actions, especially in the immune system. It markedly attenuates the activation of microglia and interferes with inflammatory signaling processes by decreasing the expression of proinflammatory cytokines [3] . Furthermore, OxATP blocks a sustained increase in [Ca 2+ ] i through the P2X 7 R pores and then inhibits the activation of caspase and apoptotic cascades in lipopolysaccharide-induced inflammatory responses [20, 62] . The inhibition of P2X 7 R-mediated signals
by OxATP limits post-ischemic inflammatory responses and confers neuroprotection [62] . OxATP prevents both the upregulation of P2X 7 Rs and neuronal death evoked by their excitotoxic effect [3] , but only partially reduces or blocks the cellular damage in organotypic hippocampal cultures [11] .
Treatment with OxATP reduces the extent of brain damage in cerebral ischemia/reperfusion injury similar to BBG and A-438079 [51] . However, other studies indicated that ischemic injury is exacerbated by OxATP in the rat MCAO model [13] . OxATP administration exacerbates the loss of MAP2-immunoreactivity in neurons in the cerebral cortex and striatum. This discrepancy might be explained by the possibility that P2X 7 Rs, P2X 7 -like receptors, and other unknown homologous receptors are expressed in the mouse brain, and ischemic injury may cause compensatory over-expression of P2X 7 -like receptor mRNAs and induce the opposite effects [13] . KN-62 is another antagonist that may be useful for the pharmacological identification of P2X 7 Rs [3, 10] . It is also known as a selective CAM-kinase-II inhibitor, a selective antagonist of the human but not the rat P2X 7 R.
KN-62 attenuates the elevation of neuronal nitric oxide synthase serine phosphorylation induced by ischemia in MCAO animals, and plays a neuroprotective role early in ischemia [63] . cell culture [52] , indicating the efficacy of this drug in the brain. It is reported that this compound is essentially devoid of activity on other P2 receptors [64] . [51] . [34, 42, 65] . Therefore, this compound might provide a preferable approach to preventing the long-term ischemic brain injury evoked by glutamate release.
3-(5-
Reactive Blue 2 (RB2) is a sulfonic derivative anthraquinone and a non-selective antagonist of P2
receptors. It does not prevent, but rather promotes P2X 7 R expression in microglia and marks their transition from the resting to the reactive state within 24 h after MCAO [4] .
This phenomenon occurs after brief treatment with RB2.
Long-term RB2 treatment of rats eliminates the effect of P2X 7 R blockade in preventing microglial activation and ameliorating the ischemic brain injury in the penumbra.
Nevertheless, in remote brain regions, it promotes the expression of P2X 7 Rs on reactive microglia, developing defensive and reparative processes [62] . Whether the neuroprotective action of RB2 is solely dependent on the modulation of P2X 7 Rs in microglia, or on additional P2
receptors is still unclear.
Conclusion
After cerebral ischemia, the penumbra is damaged but cells within this area can be saved. Consequently, the functional loss associated with stroke can be limited.
Strong stimulation of P2X 7 Rs, which is likely to involve large and nonselective pore formation, leads to cell death of both neurons and certain glial cells, especially microglia.
Inhibition of P2X 7 R activation to reduce the excitotoxic effect of Ca 2+ overload, inflammation, and glutamate release would protect against neuronal death and suppress microglial activation.
So far, the physiological functions and the contribution of P2X 7 Rs in cerebral ischemic injury remain unclear, even though such information is essential for the evaluation of the P2X 7 R as an effective therapeutic target. Whether inhibition of P2X 7 Rs has beneficial or harmful effects on brain ischemic injury and whether P2X 7 R over-expression drives microglial activation or, conversely, P2X 7 R overexpression is a consequence of microglial activation are still not known. The activation of P2X 7 Rs to induce neuroinflammation acts as a double-edged sword none the less. Further investigations to discover novel, potent, and more selective P2X 7 R antagonists will be critical to evaluate this target's potential therapeutic use, and may provide novel tools both for clinical and research purposes.
